Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Martí MJ[au]:

Clinical manifestations of the anti-IgLON5 disease. Gaig C et al. Neurology. (2017)

Reply. Tell-Martí G et al. Ann Neurol. (2016)

Clinical Practice: Evidence-Based Recommendations for the Treatment of Cervical Dystonia with Botulinum Toxin. Contarino MF et al. Front Neurol. (2017)

Search results

Items: 1 to 50 of 203

1.

Parkinson's disease as a systemic pathology.

Ezquerra M, Martí MJ, Fernández-Santiago R.

Aging (Albany NY). 2019 Feb 11. doi: 10.18632/aging.101824. [Epub ahead of print] No abstract available.

2.
3.

Differential Progression of Regional Hippocampal Atrophy in Aging and Parkinson's Disease.

Uribe C, Segura B, Baggio HC, Campabadal A, Abos A, Compta Y, Marti MJ, Valldeoriola F, Bargallo N, Junque C.

Front Aging Neurosci. 2018 Oct 11;10:325. doi: 10.3389/fnagi.2018.00325. eCollection 2018.

4.

Simultaneous low-frequency deep brain stimulation of the substantia nigra pars reticulata and high-frequency stimulation of the subthalamic nucleus to treat levodopa unresponsive freezing of gait in Parkinson's disease: A pilot study.

Valldeoriola F, Muñoz E, Rumià J, Roldán P, Cámara A, Compta Y, Martí MJ, Tolosa E.

Parkinsonism Relat Disord. 2018 Sep 5. pii: S1353-8020(18)30393-6. doi: 10.1016/j.parkreldis.2018.09.008. [Epub ahead of print]

5.

Lack of central and peripheral nervous system synuclein pathology in R1441G LRRK2-associated Parkinson's disease.

Vilas D, Gelpi E, Aldecoa I, Grau O, Rodriguez-Diehl R, Jaumà S, Martí MJ, Tolosa E.

J Neurol Neurosurg Psychiatry. 2018 Jul 27. pii: jnnp-2018-318473. doi: 10.1136/jnnp-2018-318473. [Epub ahead of print] No abstract available.

PMID:
30054313
6.

Diagnostic Accuracy, Item Analysis and Age Effects of the UPSIT Spanish Version in Parkinson's Disease.

Campabadal A, Segura B, Baggio HC, Abos A, Uribe C, Garcia-Diaz AI, Marti MJ, Valldeoriola F, Compta Y, Bargallo N, Junque C.

Arch Clin Neuropsychol. 2018 Jul 11. doi: 10.1093/arclin/acy053. [Epub ahead of print]

PMID:
30007334
7.

MTOR Pathway-Based Discovery of Genetic Susceptibility to L-DOPA-Induced Dyskinesia in Parkinson's Disease Patients.

Martín-Flores N, Fernández-Santiago R, Antonelli F, Cerquera C, Moreno V, Martí MJ, Ezquerra M, Malagelada C.

Mol Neurobiol. 2018 Jul 10. doi: 10.1007/s12035-018-1219-1. [Epub ahead of print]

PMID:
29992529
8.

Unilateral pallidal stimulation for disabling dystonia due to Rasmussen's disease.

Carreño M, Martí MJ, Aldecoa I, Painous C, Conde E, Valldeoriola F, Valls-Solé J, Bargalló N, Gil F, Manzanares I, Setoain X, Donaire A, Muñoz E, Roldán P, Boget T, Pintor L, Bailles E, Rumià J.

J Neurol Neurosurg Psychiatry. 2019 Jan;90(1):108-110. doi: 10.1136/jnnp-2018-318029. Epub 2018 Jul 9.

PMID:
29986904
9.

MicroRNA alterations in iPSC-derived dopaminergic neurons from Parkinson disease patients.

Tolosa E, Botta-Orfila T, Morató X, Calatayud C, Ferrer-Lorente R, Martí MJ, Fernández M, Gaig C, Raya Á, Consiglio A, Ezquerra M, Fernández-Santiago R.

Neurobiol Aging. 2018 Sep;69:283-291. doi: 10.1016/j.neurobiolaging.2018.05.032. Epub 2018 May 31.

PMID:
29935433
10.

Axial motor clues to identify atypical parkinsonism: A multicentre European cohort study.

Borm CDJM, Krismer F, Wenning GK, Seppi K, Poewe W, Pellecchia MT, Barone P, Johnsen EL, Østergaard K, Gurevich T, Djaldetti R, Sambati L, Cortelli P, Petrović I, Kostić VS, Brožová H, Růžička E, Marti MJ, Tolosa E, Canesi M, Post B, Nonnekes J, Bloem BR; European MSA Study Group (EMSA-SG).

Parkinsonism Relat Disord. 2018 Nov;56:33-40. doi: 10.1016/j.parkreldis.2018.06.015. Epub 2018 Jun 8.

PMID:
29910157
11.

Exhaustion of mitochondrial and autophagic reserve may contribute to the development of LRRK2 G2019S -Parkinson's disease.

Juárez-Flores DL, González-Casacuberta I, Ezquerra M, Bañó M, Carmona-Pontaque F, Catalán-García M, Guitart-Mampel M, Rivero JJ, Tobias E, Milisenda JC, Tolosa E, Marti MJ, Fernández-Santiago R, Cardellach F, Morén C, Garrabou G.

J Transl Med. 2018 Jun 8;16(1):160. doi: 10.1186/s12967-018-1526-3.

12.

[Hypercalcemia, monoclonal peak and leukemic presentation of a High-grade B-cell lymphoma with MYC, BCL-2 and BCL-6 translocations (triple hit). Report of one case].

Peña C, Marti MJ, Villegas P, Undurraga MS.

Rev Med Chil. 2017 Nov;145(11):1485-1489. doi: 10.4067/s0034-98872017001101485. Spanish. No abstract available.

13.

Gray/White Matter Contrast in Parkinson's Disease.

Uribe C, Segura B, Baggio HC, Abos A, Garcia-Diaz AI, Campabadal A, Marti MJ, Valldeoriola F, Compta Y, Bargallo N, Junque C.

Front Aging Neurosci. 2018 Mar 27;10:89. doi: 10.3389/fnagi.2018.00089. eCollection 2018.

14.

Transcriptional alterations in skin fibroblasts from Parkinson's disease patients with parkin mutations.

González-Casacuberta I, Morén C, Juárez-Flores DL, Esteve-Codina A, Sierra C, Catalán-García M, Guitart-Mampel M, Tobías E, Milisenda JC, Pont-Sunyer C, Martí MJ, Cardellach F, Tolosa E, Artuch R, Ezquerra M, Fernández-Santiago R, Garrabou G.

Neurobiol Aging. 2018 May;65:206-216. doi: 10.1016/j.neurobiolaging.2018.01.021. Epub 2018 Feb 7. Erratum in: Neurobiol Aging. 2018 Sep;69:300.

PMID:
29501959
15.

α-synuclein (SNCA) but not dynamin 3 (DNM3) influences age at onset of leucine-rich repeat kinase 2 (LRRK2) Parkinson's disease in Spain.

Fernández-Santiago R, Garrido A, Infante J, González-Aramburu I, Sierra M, Fernández M, Valldeoriola F, Muñoz E, Compta Y, Martí MJ, Ríos J, Tolosa E, Ezquerra M; Barcelona LRRK2 Study Group†.

Mov Disord. 2018 Apr;33(4):637-641. doi: 10.1002/mds.27295. Epub 2018 Feb 23.

PMID:
29473656
16.

Statistical inference in brain graphs using threshold-free network-based statistics.

Baggio HC, Abos A, Segura B, Campabadal A, Garcia-Diaz A, Uribe C, Compta Y, Marti MJ, Valldeoriola F, Junque C.

Hum Brain Mapp. 2018 Jun;39(6):2289-2302. doi: 10.1002/hbm.24007. Epub 2018 Feb 15.

PMID:
29450940
17.

Cortical atrophy patterns in early Parkinson's disease patients using hierarchical cluster analysis.

Uribe C, Segura B, Baggio HC, Abos A, Garcia-Diaz AI, Campabadal A, Marti MJ, Valldeoriola F, Compta Y, Tolosa E, Junque C.

Parkinsonism Relat Disord. 2018 May;50:3-9. doi: 10.1016/j.parkreldis.2018.02.006. Epub 2018 Feb 8.

18.

Ubiquinone, ubiquinol, 4-hydroxybenzoic acid… What 'coenzyme Q10' should we care about in multiple system atrophy?

Compta Y, Muñoz E, Martí MJ.

Parkinsonism Relat Disord. 2018 May;50:117-118. doi: 10.1016/j.parkreldis.2018.01.020. Epub 2018 Feb 5. No abstract available.

PMID:
29433994
19.

l-Dopa/carbidopa intestinal gel and subthalamic nucleus stimulation: Effects on cognition and behavior.

Valldeoriola F, Santacruz P, Ríos J, Compta Y, Rumià J, Muñoz JE, Martí MJ, Tolosa E.

Brain Behav. 2017 Oct 20;7(11):e00848. doi: 10.1002/brb3.848. eCollection 2017 Nov.

20.

Discovering the 3' UTR-mediated regulation of alpha-synuclein.

Marchese D, Botta-Orfila T, Cirillo D, Rodriguez JA, Livi CM, Fernández-Santiago R, Ezquerra M, Martí MJ, Bechara E, Tartaglia GG; Catalan MSA Registry (CMSAR).

Nucleic Acids Res. 2017 Dec 15;45(22):12888-12903. doi: 10.1093/nar/gkx1048.

21.

Cortical thinning correlates of changes in visuospatial and visuoperceptual performance in Parkinson's disease: A 4-year follow-up.

Garcia-Diaz AI, Segura B, Baggio HC, Uribe C, Campabadal A, Abos A, Marti MJ, Valldeoriola F, Compta Y, Bargallo N, Junque C.

Parkinsonism Relat Disord. 2018 Jan;46:62-68. doi: 10.1016/j.parkreldis.2017.11.003. Epub 2017 Nov 7.

22.

Parkinson disease: What goes around comes around: cognitive impairment as prodromal parkinsonism?

Compta Y, Martí MJ.

Nat Rev Neurol. 2017 Dec;13(12):709-710. doi: 10.1038/nrneurol.2017.159. Epub 2017 Nov 10. No abstract available.

PMID:
29123250
23.

Cerebrospinal fluid levels of coenzyme Q10 are reduced in multiple system atrophy.

Compta Y, Giraldo DM, Muñoz E, Antonelli F, Fernández M, Bravo P, Soto M, Cámara A, Torres F, Martí MJ; Catalan MSA Registry (CMSAR).

Parkinsonism Relat Disord. 2018 Jan;46:16-23. doi: 10.1016/j.parkreldis.2017.10.010. Epub 2017 Oct 20.

PMID:
29107645
24.

Clinical rating scale for pantothenate kinase-associated neurodegeneration: A pilot study.

Darling A, Tello C, Martí MJ, Garrido C, Aguilera-Albesa S, Tomás Vila M, Gastón I, Madruga M, González Gutiérrez L, Ramos Lizana J, Pujol M, Gavilán Iglesias T, Tustin K, Lin JP, Zorzi G, Nardocci N, Martorell L, Lorenzo Sanz G, Gutiérrez F, García PJ, Vela L, Hernández Lahoz C, Ortigoza Escobar JD, Martí Sánchez L, Moreira F, Coelho M, Correia Guedes L, Castro Caldas A, Ferreira J, Pires P, Costa C, Rego P, Magalhães M, Stamelou M, Cuadras Pallejà D, Rodríguez-Blazquez C, Martínez-Martín P, Lupo V, Stefanis L, Pons R, Espinós C, Temudo T, Pérez Dueñas B.

Mov Disord. 2017 Nov;32(11):1620-1630. doi: 10.1002/mds.27129. Epub 2017 Aug 28.

PMID:
28845923
25.

Differential diagnosis between Parkinson's disease and essential tremor using the smartphone's accelerometer.

Barrantes S, Sánchez Egea AJ, González Rojas HA, Martí MJ, Compta Y, Valldeoriola F, Simo Mezquita E, Tolosa E, Valls-Solè J.

PLoS One. 2017 Aug 25;12(8):e0183843. doi: 10.1371/journal.pone.0183843. eCollection 2017.

26.

Structural Brain Correlations of Visuospatial and Visuoperceptual Tests in Parkinson's Disease.

Garcia-Diaz AI, Segura B, Baggio HC, Marti MJ, Valldeoriola F, Compta Y, Bargallo N, Uribe C, Campabadal A, Abos A, Junque C.

J Int Neuropsychol Soc. 2018 Jan;24(1):33-44. doi: 10.1017/S1355617717000583. Epub 2017 Jul 17.

27.

Characterization of patients with longstanding idiopathic REM sleep behavior disorder.

Iranzo A, Stefani A, Serradell M, Martí MJ, Lomeña F, Mahlknecht P, Stockner H, Gaig C, Fernández-Arcos A, Poewe W, Tolosa E, Högl B, Santamaria J; SINBAR (Sleep Innsbruck Barcelona) group.

Neurology. 2017 Jul 18;89(3):242-248. doi: 10.1212/WNL.0000000000004121. Epub 2017 Jun 14.

PMID:
28615430
28.

CSF sAPPβ, YKL-40, and neurofilament light in frontotemporal lobar degeneration.

Alcolea D, Vilaplana E, Suárez-Calvet M, Illán-Gala I, Blesa R, Clarimón J, Lladó A, Sánchez-Valle R, Molinuevo JL, García-Ribas G, Compta Y, Martí MJ, Piñol-Ripoll G, Amer-Ferrer G, Noguera A, García-Martín A, Fortea J, Lleó A.

Neurology. 2017 Jul 11;89(2):178-188. doi: 10.1212/WNL.0000000000004088. Epub 2017 Jun 7.

PMID:
28592456
29.

Brain correlates of progressive olfactory loss in Parkinson's disease.

Campabadal A, Uribe C, Segura B, Baggio HC, Abos A, Garcia-Diaz AI, Marti MJ, Valldeoriola F, Compta Y, Bargallo N, Junque C.

Parkinsonism Relat Disord. 2017 Aug;41:44-50. doi: 10.1016/j.parkreldis.2017.05.005. Epub 2017 May 10.

30.

Regional Overlap of Pathologies in Lewy Body Disorders.

Colom-Cadena M, Grau-Rivera O, Planellas L, Cerquera C, Morenas E, Helgueta S, Muñoz L, Kulisevsky J, Martí MJ, Tolosa E, Clarimon J, Lleó A, Gelpi E.

J Neuropathol Exp Neurol. 2017 Mar 1;76(3):216-224. doi: 10.1093/jnen/nlx002.

PMID:
28395086
31.

Clinical manifestations of the anti-IgLON5 disease.

Gaig C, Graus F, Compta Y, Högl B, Bataller L, Brüggemann N, Giordana C, Heidbreder A, Kotschet K, Lewerenz J, Macher S, Martí MJ, Montojo T, Pérez-Pérez J, Puertas I, Seitz C, Simabukuro M, Téllez N, Wandinger KP, Iranzo A, Ercilla G, Sabater L, Santamaría J, Dalmau J.

Neurology. 2017 May 2;88(18):1736-1743. doi: 10.1212/WNL.0000000000003887. Epub 2017 Apr 5.

32.

Discriminating cognitive status in Parkinson's disease through functional connectomics and machine learning.

Abós A, Baggio HC, Segura B, García-Díaz AI, Compta Y, Martí MJ, Valldeoriola F, Junqué C.

Sci Rep. 2017 Mar 28;7:45347. doi: 10.1038/srep45347.

33.

Clinical Practice: Evidence-Based Recommendations for the Treatment of Cervical Dystonia with Botulinum Toxin.

Contarino MF, Van Den Dool J, Balash Y, Bhatia K, Giladi N, Koelman JH, Lokkegaard A, Marti MJ, Postma M, Relja M, Skorvanek M, Speelman JD, Zoons E, Ferreira JJ, Vidailhet M, Albanese A, Tijssen MA.

Front Neurol. 2017 Feb 24;8:35. doi: 10.3389/fneur.2017.00035. eCollection 2017. Review.

34.

Cross-sectional and longitudinal associations of motor fluctuations and non-motor predominance with cerebrospinal τ and Aβ as well as dementia-risk in Parkinson's disease.

Modreanu R, Cerquera SC, Martí MJ, Ríos J, Sánchez-Gómez A, Cámara A, Fernández M, Compta Y.

J Neurol Sci. 2017 Feb 15;373:223-229. doi: 10.1016/j.jns.2016.12.064. Epub 2016 Dec 30.

PMID:
28131192
35.

Lack of evidence for a role of genetic variation in TMEM230 in the risk for Parkinson's disease in the Caucasian population.

Giri A, Mok KY, Jansen I, Sharma M, Tesson C, Mangone G, Lesage S, Bras JM, Shulman JM, Sheerin UM; International Parkinson's Disease Consortium (IPDGC), Díez-Fairen M, Pastor P, Martí MJ, Ezquerra M, Tolosa E, Correia-Guedes L, Ferreira J, Amin N, van Duijn CM, van Rooij J, Uitterlinden AG, Kraaij R, Nalls M, Simón-Sánchez J.

Neurobiol Aging. 2017 Feb;50:167.e11-167.e13. doi: 10.1016/j.neurobiolaging.2016.10.004. Epub 2016 Oct 11.

36.

Cross-Sectional and Longitudinal Cognitive Correlates of FDDNP PET and CSF Amyloid-β and Tau in Parkinson's Disease1.

Buongiorno M, Antonelli F, Compta Y, Fernandez Y, Pavia J, Lomeña F, Ríos J, Ramírez I, García JR, Soler M, Cámara A, Fernández M, Basora M, Salazar F, Sanchez-Etayo G, Valldeoriola F, Barrio JR, Marti MJ.

J Alzheimers Dis. 2017;55(3):1261-1272.

PMID:
27814297
37.

Plasma miR-34a-5p and miR-545-3p as Early Biomarkers of Alzheimer's Disease: Potential and Limitations.

Cosín-Tomás M, Antonell A, Lladó A, Alcolea D, Fortea J, Ezquerra M, Lleó A, Martí MJ, Pallàs M, Sanchez-Valle R, Molinuevo JL, Sanfeliu C, Kaliman P.

Mol Neurobiol. 2017 Sep;54(7):5550-5562. doi: 10.1007/s12035-016-0088-8. Epub 2016 Sep 8.

PMID:
27631879
38.

Conjoint FTLD-FUS of the neuronal intermediate filament inclusion disease type, progressive supranuclear palsy and Alzheimer's pathology presenting as parkinsonism with early falls and late hallucinations, psychosis and dementia.

Compta Y, Ramos-Campoy O, Grau-Rivera O, Colom-Cadena M, Clarimón J, Martí MJ, Gelpi E.

Neuropathol Appl Neurobiol. 2017 Jun;43(4):352-357. doi: 10.1111/nan.12340. No abstract available.

PMID:
27490935
39.

White matter hyperintensities, cerebrospinal amyloid-β and dementia in Parkinson's disease.

Compta Y, Buongiorno M, Bargalló N, Valldeoriola F, Muñoz E, Tolosa E, Ríos J, Cámara A, Fernández M, Martí MJ.

J Neurol Sci. 2016 Aug 15;367:284-90. doi: 10.1016/j.jns.2016.06.009. Epub 2016 Jun 11. No abstract available.

PMID:
27423605
40.

Patterns of cortical thinning in nondemented Parkinson's disease patients.

Uribe C, Segura B, Baggio HC, Abos A, Marti MJ, Valldeoriola F, Compta Y, Bargallo N, Junque C.

Mov Disord. 2016 May;31(5):699-708. doi: 10.1002/mds.26590. Epub 2016 Apr 20.

41.

Erratum to: COPPADIS-2015 (COhort of Patients with PArkinson's DIsease in Spain, 2015), a global--clinical evaluations, serum biomarkers, genetic studies and neuroimaging--prospective, multicenter, non-interventional, long-term study on Parkinson's disease progression.

Santos-García D, Mir P, Cubo E, Vela L, Rodríguez-Oroz MC, Martí MJ, Arbelo JM, Infante J, Kulisevsky J, Martínez-Martín P; COPPADIS Study Group.

BMC Neurol. 2016 Apr 6;16:44. doi: 10.1186/s12883-016-0567-6. No abstract available.

42.

Pisa syndrome in a patient with pathologically confirmed Parkinson's disease.

Solla P, Grau-Rivera O, Gelpi E, Marrosu F, Martí MJ.

Neuropathol Appl Neurobiol. 2016 Dec;42(7):654-658. doi: 10.1111/nan.12324. Epub 2016 Apr 28. No abstract available.

PMID:
26999006
43.

Reply.

Tell-Martí G, Puig-Butille JA, Potrony M, Badenas C, Milà M, Malvehy J, Martí MJ, Ezquerra M, Fernández-Santiago R, Puig S.

Ann Neurol. 2016 May;79(5):868. doi: 10.1002/ana.24629. Epub 2016 Mar 22. No abstract available.

PMID:
26934067
44.

COPPADIS-2015 (COhort of Patients with PArkinson's DIsease in Spain, 2015), a global--clinical evaluations, serum biomarkers, genetic studies and neuroimaging--prospective, multicenter, non-interventional, long-term study on Parkinson's disease progression.

Santos-García D, Mir P, Cubo E, Vela L, Rodríguez-Oroz MC, Martí MJ, Arbelo JM, Infante J, Kulisevsky J, Martínez-Martín P; COPPADIS Study Group.

BMC Neurol. 2016 Feb 25;16:26. doi: 10.1186/s12883-016-0548-9. Erratum in: BMC Neurol. 2016;16:44.

45.

Management of dystonia in Europe: a survey of the European network for the study of the dystonia syndromes.

Valadas A, Contarino MF, Albanese A, Bhatia KP, Falup-Pecurariu C, Forsgren L, Friedman A, Giladi N, Hutchinson M, Kostic VS, Krauss JK, Lokkegaard A, Marti MJ, Milanov I, Pirtosek Z, Relja M, Skorvanek M, Stamelou M, Stepens A, Tamás G, Taravari A, Tzoulis C, Vandenberghe W, Vidailhet M, Ferreira JJ, Tijssen MA.

Eur J Neurol. 2016 Apr;23(4):772-9. doi: 10.1111/ene.12940. Epub 2016 Jan 29.

PMID:
26826067
46.

Lewy- and Alzheimer-type pathologies in midbrain and cerebellum across the Lewy body disorders spectrum.

Sierra M, Gelpi E, Martí MJ, Compta Y.

Neuropathol Appl Neurobiol. 2016 Aug;42(5):451-62. doi: 10.1111/nan.12308. Epub 2016 Apr 1.

PMID:
26810462
47.

Prolonged-release oxycodone-naloxone for treatment of severe pain in patients with Parkinson's disease (PANDA): a double-blind, randomised, placebo-controlled trial.

Trenkwalder C, Chaudhuri KR, Martinez-Martin P, Rascol O, Ehret R, Vališ M, Sátori M, Krygowska-Wajs A, Marti MJ, Reimer K, Oksche A, Lomax M, DeCesare J, Hopp M; PANDA study group.

Lancet Neurol. 2015 Dec;14(12):1161-70. doi: 10.1016/S1474-4422(15)00243-4. Epub 2015 Oct 19.

PMID:
26494524
48.

Neutralizing Antibody and Botulinum Toxin Therapy: A Systematic Review and Meta-analysis.

Fabbri M, Leodori G, Fernandes RM, Bhidayasiri R, Marti MJ, Colosimo C, Ferreira JJ.

Neurotox Res. 2016 Jan;29(1):105-17. Review.

PMID:
26467676
49.

Reply.

Tell-Martí G, Puig-Butille JA, Potrony M, Badenas C, Milà M, Malvehy J, Martí MJ, Ezquerra M, Fernández-Santiago R, Puig S.

Ann Neurol. 2016 Jan;79(1):161-3. doi: 10.1002/ana.24526. Epub 2015 Dec 12. No abstract available.

PMID:
26389780
50.

Clinical and imaging markers in premotor LRRK2 G2019S mutation carriers.

Vilas D, Ispierto L, Álvarez R, Pont-Sunyer C, Martí MJ, Valldeoriola F, Compta Y, de Fabregues O, Hernández-Vara J, Puente V, Calopa M, Jaumà S, Campdelacreu J, Aguilar M, Quílez P, Casquero P, Lomeña F, Ríos J, Tolosa E.

Parkinsonism Relat Disord. 2015 Oct;21(10):1170-6. doi: 10.1016/j.parkreldis.2015.08.007. Epub 2015 Aug 12.

PMID:
26306001

Supplemental Content

Loading ...
Support Center